Page last updated: 2024-09-03

pak 104p and 3,3'-diethyloxacarbocyanine

pak 104p has been researched along with 3,3'-diethyloxacarbocyanine in 1 studies

Compound Research Comparison

Studies (pak 104p)	Trials (pak 104p)	Recent Studies (post-2010) (pak 104p)	Studies (3,3'-diethyloxacarbocyanine)	Trials (3,3'-diethyloxacarbocyanine)	Recent Studies (post-2010) (3,3'-diethyloxacarbocyanine)
16	0	0	24	0	5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Minderman, H; Minderman, MD; Rustum, YM; Slovak, ML; Toth, K; Vanhoefer, U; Wrzosek, C; Yin, MB	1

Other Studies

1 other study(ies) available for pak 104p and 3,3'-diethyloxacarbocyanine

Article	Year
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux. Cytometry, 1996, Sep-01, Volume: 25, Issue:1 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbocyanines; Cyclic P-Oxides; Doxorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Fluorescent Dyes; Humans; Neoplasm Proteins; Nicotinic Acids; Rhodamine 123; Rhodamines; Tumor Cells, Cultured	1996

Article

Year

DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.

Cytometry, 1996, Sep-01, Volume: 25, Issue:1

Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbocyanines; Cyclic P-Oxides; Doxorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Fluorescent Dyes; Humans; Neoplasm Proteins; Nicotinic Acids; Rhodamine 123; Rhodamines; Tumor Cells, Cultured

1996